| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.25B | 67.01B | 69.87B | 68.09B | 63.32B | 69.98B |
| Gross Profit | 33.68B | 20.81B | 33.42B | 33.00B | 29.15B | 36.19B |
| EBITDA | 9.73B | 9.51B | 9.00B | 9.30B | 9.29B | 14.89B |
| Net Income | 4.44B | 3.77B | 3.70B | 3.50B | 4.41B | 8.34B |
Balance Sheet | ||||||
| Total Assets | 72.18B | 75.37B | 71.61B | 75.63B | 68.29B | 64.89B |
| Cash, Cash Equivalents and Short-Term Investments | 7.81B | 8.47B | 6.81B | 4.84B | 3.46B | 2.75B |
| Total Debt | 16.05B | 18.29B | 16.35B | 21.26B | 14.42B | 15.97B |
| Total Liabilities | 26.00B | 27.65B | 25.40B | 32.46B | 26.35B | 26.44B |
| Stockholders Equity | 46.19B | 47.71B | 46.21B | 43.15B | 41.93B | 38.45B |
Cash Flow | ||||||
| Free Cash Flow | 5.45B | 3.93B | 7.15B | -3.60B | 6.47B | 5.41B |
| Operating Cash Flow | 6.45B | 7.08B | 9.45B | 2.87B | 14.26B | 9.03B |
| Investing Cash Flow | -3.98B | -7.37B | -2.05B | -7.18B | -11.65B | -3.43B |
| Financing Cash Flow | -2.97B | -240.00M | -6.82B | 3.40B | -4.10B | -3.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹129.21B | 31.20 | ― | 1.18% | 11.70% | 17.01% | |
68 Neutral | ₹360.39B | 41.61 | ― | 0.52% | 4.11% | 257.30% | |
66 Neutral | ₹178.11B | 23.47 | ― | 1.13% | 0.86% | -15.59% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ₹63.83B | 50.83 | ― | 0.74% | -0.24% | -48.94% | |
56 Neutral | ₹130.11B | 63.66 | ― | 1.25% | -10.87% | -68.10% | |
54 Neutral | ₹120.11B | 31.87 | ― | 1.84% | -4.09% | 1.59% |